BackMatinas Biopharma Holdings Overview

Matinas Biopharma Holdings Total Liabilities

Track Matinas Biopharma Holdings's total liabilities ($1.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.61M
↓ 57.00% YoYΔ $-2.14M vs prior year quarter

Peer trimmed avg / median

Loading

Matinas Biopharma Holdings Total Liabilities History

Loading

Matinas Biopharma Holdings vs. peers: Total Liabilities Comparison

Loading

Matinas Biopharma Holdings Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Matinas Biopharma Holdings (MTNB) FAQ

As of the most recent data (June 2026), MTNB shows a total liabilities of $1.6M. That compares with $3.7M in the prior-year period — down 57.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MTNB's total liabilities is now $1.6M (was $3.7M) — a 57.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Matinas Biopharma Holdings is outperforming or lagging.

Tracking MTNB's total liabilities over time shows whether Matinas Biopharma Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6M That compares with $3.7M in the prior-year period — down 57.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Matinas Biopharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.6M) with ownership activity and broader fundamentals.

Matinas Biopharma Holdings's total liabilities is $1.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.